Skip to main content

Table 2 Survival and incidence of new breast cancer related to breast density

From: Mammographic density as a predictor of breast cancer survival: the Multiethnic Cohort

Outcome

Model

Label

Per 10% density

Percent densitya

Percent density categories

    

Low

High

< 25%

25 to < 50%

≥ 50%

Breast cancer death

All

Number

607

304

303

215

209

183

  

Deaths

27

12

15

9

7

11

  

HRb

0.95

1

0.83

1

0.60

0.89

  

95% CI

0.79-1.15

 

0.36-1.92

 

0.22-1.66

0.34-2.33

  

P value

0.61

 

0.67

 

0.33

0.80

 

All plus interaction (density × radiation)

Number

607

304

303

215

209

183

  

Deaths

27

12

15

9

7

11

  

HRb

1.38

1

5.31

1

0.96

2.54

  

95% CI

0.99-1.92

 

0.66-43.1

 

0.33-2.79

0.65-9.88

  

P value

0.06

 

0.12

 

0.94

0.18

 

With radiation

Number

361

175

170

128

131

102

  

Deaths

16

11

5

9

2

5

  

HRb

0.77

1

0.33

1

0.19

0.42

  

95% CI

0.60-0.99

 

0.11-1.06

 

0.04-0.91

0.12-1.40

  

P value

0.04

 

0.06

 

0.04

0.16

 

Without radiation

Number

246

118

128

87

78

81

  

Deaths

11

1

10

0

5

6

  

HR

1.46

1

5.57

 

1

1.34

  

95% CI

1.00-2.14

 

0.65-48.0

  

0.34-5.34

  

P value

0.05

 

0.12

  

0.68

Other causes of death

All

Number

607

304

303

215

209

183

  

Deaths

100

55

45

44

28

28

  

HRb

1.08

 

1.37

 

1.06

1.32

  

95% CI

0.98-1.20

 

0.88-2.13

 

0.64-1.75

0.77-2.25

  

P value

0.13

 

0.16

 

0.83

0.32

Second breast cancer

All plus interaction (density × radiation)

Number

607

304

303

215

209

183

  

Cases

71

32

39

22

23

26

  

HRb

1.13

1

1.72

1

1.31

2.11

  

95% CI

0.96-1.33

 

0.88-2.55

 

0.69-2.50

0.98-4.50

  

P value

0.14

 

0.15

 

0.41

0.06

  1. aLow density = < 35%; high density ≥ 35%. bHazard ratios (HRs) and 95% confidence intervals (CIs) for the effect of density estimated by Cox regression with adjustment for age at diagnosis, ethnicity, overweight/obesity, stage of disease at diagnosis (in situ, localized, or advanced), and radiation treatment when applicable.